Logo image of DRCT

DIRECT DIGITAL HOLDINGS IN-A (DRCT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DRCT - US25461T1051 - Common Stock

4.11 USD
+1.8 (+77.92%)
Last: 1/23/2026, 8:00:02 PM
4.0384 USD
-0.07 (-1.74%)
After Hours: 1/23/2026, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, DRCT scores 1 out of 10 in our fundamental rating. DRCT was compared to 92 industry peers in the Media industry. DRCT has a bad profitability rating. Also its financial health evaluation is rather negative. DRCT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year DRCT has reported negative net income.
  • In the past year DRCT has reported a negative cash flow from operations.
  • In the past 5 years DRCT reported 4 times negative net income.
  • In multiple years DRCT reported negative operating cash flow during the last 5 years.
DRCT Yearly Net Income VS EBIT VS OCF VS FCFDRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • The Return On Assets of DRCT (-42.00%) is worse than 76.09% of its industry peers.
Industry RankSector Rank
ROA -42%
ROE N/A
ROIC N/A
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DRCT Yearly ROA, ROE, ROICDRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400 -400

1.3 Margins

  • DRCT has a Gross Margin of 31.43%. This is comparable to the rest of the industry: DRCT outperforms 41.30% of its industry peers.
  • DRCT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DRCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
DRCT Yearly Profit, Operating, Gross MarginsDRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40

0

2. Health

2.1 Basic Checks

  • DRCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DRCT has more shares outstanding
  • The debt/assets ratio for DRCT is higher compared to a year ago.
DRCT Yearly Shares OutstandingDRCT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
DRCT Yearly Total Debt VS Total AssetsDRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • DRCT has an Altman-Z score of 0.92. This is a bad value and indicates that DRCT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.92, DRCT perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACCN/A
WACC9.2%
DRCT Yearly LT Debt VS Equity VS FCFDRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.37 indicates that DRCT may have some problems paying its short term obligations.
  • DRCT's Current ratio of 0.37 is on the low side compared to the rest of the industry. DRCT is outperformed by 84.78% of its industry peers.
  • DRCT has a Quick Ratio of 0.37. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DRCT's Quick ratio of 0.37 is on the low side compared to the rest of the industry. DRCT is outperformed by 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
DRCT Yearly Current Assets VS Current LiabilitesDRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

  • The earnings per share for DRCT have decreased strongly by -1762.87% in the last year.
  • DRCT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.46%.
  • The Revenue has been growing by 17.76% on average over the past years. This is quite good.
EPS 1Y (TTM)-1762.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-534.62%
Revenue 1Y (TTM)-62.46%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-12.02%

3.2 Future

  • Based on estimates for the next years, DRCT will show a very strong growth in Earnings Per Share. The EPS will grow by 34.33% on average per year.
  • Based on estimates for the next years, DRCT will show a very negative growth in Revenue. The Revenue will decrease by -10.39% on average per year.
EPS Next Y-1659.23%
EPS Next 2Y34.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-35.97%
Revenue Next 2Y-10.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRCT Yearly Revenue VS EstimatesDRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
DRCT Yearly EPS VS EstimatesDRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 20 -20 -40 -60 -80

1

4. Valuation

4.1 Price/Earnings Ratio

  • DRCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRCT Price Earnings VS Forward Price EarningsDRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRCT Per share dataDRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

  • DRCT's earnings are expected to grow with 34.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • DRCT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DIRECT DIGITAL HOLDINGS IN-A / DRCT FAQ

What is the fundamental rating for DRCT stock?

ChartMill assigns a fundamental rating of 1 / 10 to DRCT.


What is the valuation status of DIRECT DIGITAL HOLDINGS IN-A (DRCT) stock?

ChartMill assigns a valuation rating of 1 / 10 to DIRECT DIGITAL HOLDINGS IN-A (DRCT). This can be considered as Overvalued.


What is the profitability of DRCT stock?

DIRECT DIGITAL HOLDINGS IN-A (DRCT) has a profitability rating of 1 / 10.


Can you provide the financial health for DRCT stock?

The financial health rating of DIRECT DIGITAL HOLDINGS IN-A (DRCT) is 0 / 10.